Berkeley's MIT, Harvard CRISPR Battle Hinges on Expectations

May 9, 2018

On April 30, the University of California (UC) at Berkeley pressed its case to reverse a patent board decision in a high-stakes fight over intellectual property rights to the revolutionary gene-editing technology CRISPR-Cas9.

Related Stories